Immune Therapeutics Issues Special Letter to Shareholders
Jan 30, 2017 13:40 pm UTC| Business
Company Expects to Report Initial Revenues in FirstHalf of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla., Jan. 30, 2017 -- Immune...
Global Oatmeal Market will reach USD 2.50 Billion by 2022: Zion Market Research
Jan 30, 2017 13:36 pm UTC| Business
Sarasota, FL, Jan. 30, 2017 -- Zion Market Research has published a new report titled “Oatmeal Market (Whole Oat Grains, Steel Cut Oats, Regular Rolled Oats, Instant Rolled Oats and Others) by Distribution Channel...
Mueller Water Products to Acquire Singer Valve
Jan 30, 2017 13:33 pm UTC| Business
ATLANTA, Jan. 30, 2017 -- Mueller Water Products, Inc. (NYSE:MWA) today announced that it has signed a definitive agreement to acquire Singer Valve, a manufacturer of automatic control valves, for C$34 million in...
OptimizeRx Appoints James Lang to Board of Directors
Jan 30, 2017 13:31 pm UTC| Business
ROCHESTER, Mich., Jan. 30, 2017 -- OptimizeRx Corp. (OTCQB:OPRX), the leading electronic health record (EHR) based point-of-care solution company for health care professionals and patients, has appointed James Lang to...
Jan 30, 2017 13:30 pm UTC| Business
PRINCETON, N.J., Jan. 30, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that an abstract on data from the company’s Phase 2 GOG-0265 trial...
tronc, Inc. Reports Updated 2016 Full Year Guidance and Announces 2017 Full Year Guidance
Jan 30, 2017 13:30 pm UTC| Business
Schedules Fourth Quarter 2016 Earnings Call on February 22, 2017 2016 Full Year Guidance Update: 2016 Total Revenue Guidance updated to $1.61 billion from a range of $1.61 to $1.63 billion2016 Adjusted EBITDA Guidance...
Jan 30, 2017 13:30 pm UTC| Business
WALTHAM, Mass., Jan. 30, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases...